Vyloo

Magaldrate medicines online

About Magaldrate

Magaldrate appears as an active ingredient (salt) in various prescription and OTC medicines. Use this page to browse related products listed on Vyloo and match strength and form to your prescription or prior purchase. Product information is educational for shopping only — it is not medical advice. Upload a valid prescription when the product is marked Rx.

View all results
StayHappi Magaldrate+Simethicone 400mg/20mg Oral SuspensionNon-Rx

StayHappi Magaldrate+Simethicone 400mg/20mg Oral Suspension

Sarvagunaushdhi Pvt Ltd · 170.0 ml in 1 bottle

₹35
Maglid SuspensionNon-Rx

Maglid Suspension

Overseas Healthcare Pvt Ltd · 200.0 ml in 1 bottle

₹89
Magovib Syrup Sugar FreeNon-Rx

Magovib Syrup Sugar Free

Vibcare Pharma Pvt Ltd · 170.0 ml in 1 bottle

₹70
Renocid Oral Suspension MangoNon-Rx

Renocid Oral Suspension Mango

Getron Pharmaceuticals · 170.0 ml in 1 bottle

₹70
Ultraone-M Oral Suspension Mango Sugar FreeNon-Rx

Ultraone-M Oral Suspension Mango Sugar Free

Frokeen Pharmaceuticals Pvt Ltd · 200.0 ml in 1 bottle

₹108
Ultracid-M Oral Suspension Mango Sugar FreeNon-Rx

Ultracid-M Oral Suspension Mango Sugar Free

Obsurge Biotech Ltd · 170.0 ml in 1 bottle

₹86
Ultracid-M Oral Suspension Mango Sugar FreeNon-Rx

Ultracid-M Oral Suspension Mango Sugar Free

Obsurge Biotech Ltd · 200.0 ml in 1 bottle

₹114
Zetcid MPS Oral Suspension MintNon-Rx

Zetcid MPS Oral Suspension Mint

Biophar Lifesciences Pvt Ltd · 170.0 ml in 1 bottle

₹60
Vaxant-Mps Oral Suspension Sugar FreeNon-Rx

Vaxant-Mps Oral Suspension Sugar Free

Vaxova Drugs Pvt Ltd · 170.0 ml in 1 bottle

₹70
Rodrate-Mps Oral Suspension Sugar FreeNon-Rx

Rodrate-Mps Oral Suspension Sugar Free

Ronish Bioceuticals · 170.0 ml in 1 bottle

₹68
Unigel MPS SyrupNon-Rx

Unigel MPS Syrup

Alive Healthcare · 170.0 ml in 1 bottle

₹70
One MPS Oral SuspensionNon-Rx

One MPS Oral Suspension

Apoorva Drugs & Pharmaceuticals · 170.0 ml in 1 bottle

₹70

Frequently asked questions

All salts · Health conditions · Editorial policy